Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C1R | P00736 | 4/20 | 0.66 |
| ▸ | KLK7 | P49862 | 10/20 | 0.59 |
| ▸ | KLK14 | Q9P0G3 | 10/20 | 0.59 |
| ▸ | KLK5 | Q9Y337 | 10/20 | 0.59 |
| ▸ | CTSG | P08311 | 8/20 | 0.59 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.59 |
| ▸ | ELANE | P08246 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | CTRC | Q99895 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5793545 | 0.82 | C1R (0.76) | C1RKLK7KLK14KLK5CTSG | |
| SCHEMBL5376168 | 0.82 | C1R (0.66) | C1RKLK7KLK14KLK5CTSG | |
| SCHEMBL5378586 | 0.82 | ALDH1A1 (0.66) | C1RELANEKMT2AKDM4EALDH1A1 | |
| SCHEMBL5382664 | 0.82 | ELANE (0.57) | C1RELANEMEN1KMT2AKDM4E | |
| SCHEMBL14462683 | 0.82 | NPC1 (0.55) | C1RELANEMEN1KMT2AKDM4E | |
| SCHEMBL5790698 | 0.81 | C1R (0.72) | C1RKLK7KLK14KLK5CTSG | |
| SCHEMBL30366271 | 0.80 | C1R (1.00) | C1RKLK7KLK14KLK5CTSG | |
| SCHEMBL692226 | 0.80 | C1R (1.00) | C1RKLK7KLK14KLK5CTSG | |
| SCHEMBL5382380 | 0.80 | ALDH1A1 (0.69) | C1RELANEMEN1KMT2AKDM4E | |
| SCHEMBL5794442 | 0.77 | ELANE (0.71) | C1RKLK7KLK14KLK5CTSG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7244776-B2 | Ultraviolet light absorbers | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-07-17 | — | — | US | disclosed |
| US-20070100031-A1 | Ultraviolet light absorbers | RAVICHANDRAN RAMANATHAN | 2007-05-03 | — | — | US | disclosed |
| US-7173128-B2 | Ultraviolet light absorbers | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-02-06 | — | — | US | disclosed |
| US-20040192684-A1 | Ultraviolet light absorbers | CIBA SPECIALTY CHEMICALS CORPORATION | 2004-09-30 | — | — | US | disclosed |
| EP-1430038-A1 | ULTRAVIOLET LIGHT ABSORBERS | Ciba SC Holding AG (CH) | 2004-06-23 | — | — | EP | disclosed |
| WO-2003016292-A1 | ULTRAVIOLET LIGHT ABSORBERS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-02-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040192684-A1 | Ultraviolet light absorbers | UNG, MSH6, MAL2 | C1R 3037/4885KLK7 2415/4885KLK14 1691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.